Skip to content

Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)

Preventive Strategies in Acute Respiratory Distress Syndrome

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02070666
Acronym
EPALI
Enrollment
98
Registered
2014-02-25
Start date
2014-05-31
Completion date
2020-06-30
Last updated
2020-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Keywords

ARDS, Prevention, Protective mechanical ventilation, low tidal volumes

Brief summary

The investigators hypothesis is that patients at risk of ARDS, detected by LIPS (Lung Injury Prediction Score), under mechanical ventilation could benefit from a protective ventilatory strategy (used in ARDS treatment) in order to avoid or decrease the ARDS development. This would lead to a decrease in incidence, mortality and health care costs associated to this syndrome. This study will help to confirm the current evidence about low tidal volumes, evaluating adverse events of this strategy.

Detailed description

The main objective is to evaluate the effect of a protective ventilatory strategy by using lower tidal volumes compared to the use of traditionally volumes in ARDS development.

Interventions

BEHAVIORALProtective mechanical ventilation

Ventilation mode: volume control, pressure control, dual modes (It is allowed to change to a spontaneous mode; a minimum of 5 cmH2O level of support should be used; in case the resulting tidal volume exceeds 6 mL/kg PBW this is accepted. This is not a reason to use more sedation and/or muscle relaxants, or to switch the ventilator to a controlled mode of ventilation). * Tidal volume: 6 mL/Kg PBW, decreasing 1 mL/kg PBW each step if necessary (steps of 5 minutes), to maintain plateau pressure \< 25 cmH2O until a minimum tidal volume of 4 mL/Kg PBW, unless the patient suffers from severe dyspnea or unacceptable acidosis. * Fraction of inspired oxygen inspired oxygen fraction (FiO2) \> 0.21 to maintain oxygen saturation 90-92%. * PEEP ≥ 5 cmH2O, and optimized to maintain Oxygen saturation (SpO2) 90-92% (left to the discretion of the attending physician). * Plateau pressure ≤ 25 cmH2O

BEHAVIORALControl group

Ventilation mode: volume control, pressure control, dual modes (It is allowed to change to a spontaneous mode, with the level of support adjusted to reach tidal volumes minimum of 8 mL/kg predicted body weight PBW; if it is not possible, the data collection should be continue and an intention-to-treat analysis will be done). * Tidal volume: minimum 8 mL/kg PBW. It is possible to increase until 10 mL/kg PBW unless plateau pressure increases above 25 cmH2O. · FiO2 \> 0.21 to maintain oxygen saturation 90-92%. * PEEP ≥ 5 cmH2O, and optimized to maintain SpO2 90-92% (left to the discretion of the attending physician). * Plateau pressure ≤ 25 cm H2O.

OTHERDead space

Volumetric capnography will be used. Dead space (Vd/Vt) measurements will be taken at baseline and daily after initiation of mechanical ventilation. Nursing and respiratory care activities (including changes to ventilator settings) will be suspended for at least 5 minutes prior to all Vd/Vt measurements.

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients within 12 hours after start of invasive mechanical ventilation (MV) and admitted to participating ICU (it is recommended an inclusion as soon as possible during the first 3 hours). * LIPS \> 4 points. * Absence of mild, moderate and severe ARDS criteria (Berlin definition). * Older than 18 year-old. * Signed informed consent

Exclusion criteria

* Bilateral pulmonary infiltrates in chest X-ray at admission. * Mechanical ventilation \> 12 hours. * Previous pneumonectomy or lobectomy. * Severe cranial trauma (Glasgow Coma Scale\<9) or cranial hypertension. * Severe chronic pulmonary disease (GOLD IV). * Admission from other hospital under MV. * Limitation of therapeutic effort. * Pregnancy. * Acute pulmonary embolism. * Participation in other interventional trials. * Previous randomized in the proposed trial. * Absence of informed consent.

Design outcomes

Primary

MeasureTime frameDescription
ARDS development7 daysTo determine the effect of a protective mechanical ventilation strategy using lower tidal volumes as compared to mechanical ventilation using traditionally-sized tidal volumes on development of ARDS.

Secondary

MeasureTime frameDescription
Atelectasis7 daysIncidence of atelectasis
Mortality90 daysIn-hospital mortality, 28-day mortality and 90-day mortality
Pneumonia7 daysIncidence of pneumonia
Dead space7 daysVolumetric capnography
Length of stayparticipants will be followed for the duration of ICU (Intensive Care Unit) and hospital stay, an expected average of 4 weeksICU stay and hospital stay
Ventilator-free days28 days after admissionFrom 1 to 28 days over 28 days in a month

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026